We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SDR:LSESchroders PLC Analysis

Data as of 2026-03-14 - not real-time

£570.50

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Schroders shares are currently trading in a bullish technical environment, with price holding above the short‑term moving average. Momentum indicators such as the RSI are in the bullish zone, supporting the upward bias. However, the MACD histogram has turned negative, hinting at potential short‑term weakness. The stock’s beta is low, indicating limited sensitivity to broader market moves. Volatility remains elevated, suggesting price swings could be sizable. Valuation metrics show the price‑to‑earnings ratio is in line with the sector, while the discounted cash‑flow model points to a substantial fair‑value gap.
The company delivers solid profitability with high gross and operating margins and a healthy return on equity. Free cash flow generation comfortably covers the dividend, and the payout ratio sits at a moderate level, making the yield appear sustainable. Recent news of a sizable takeover offer has propelled the share price sharply, yet several brokerages have trimmed their ratings, citing capped upside. The acquisition prospect introduces event‑driven uncertainty that could swing sentiment in the near term. Nonetheless, the underlying business fundamentals remain strong, and the long‑term outlook is supported by diversified global assets. Overall, the combination of attractive dividend income, undervalued assessment, and resilient earnings suggests a cautiously optimistic investment case.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Takeover offer creates near‑term price volatility
  • MACD bearish divergence signals short‑term weakness
  • Technical support level near current price

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Potential acquisition premium if deal closes
  • Strong cash flow and sustainable dividend
  • Undervalued relative to discounted cash‑flow estimate

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Resilient earnings and high profit margins
  • Diversified global asset base reduces concentration risk
  • Attractive dividend yield with moderate payout ratio

Key Metrics & Analysis

Financial Health

Revenue Growth15.50%
Profit Margin15.81%
P/E Ratio16.8
ROE12.30%
ROA2.29%
Debt/Equity12.87
P/B Ratio203.4
Op. Cash Flow£914.4M
Free Cash Flow£1.2B
Industry P/E16.4

Technical Analysis

TrendBullish
RSI62.7
Support£570.50
Resistance£588.00
MA 20£584.25
MA 50£506.41
MA 200£414.31
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair Value£2,371.66
Target Price£524.86
Upside/Downside-8.00%
GradeUndervalued
TypeBlend
Dividend Yield3.77%

Risk Assessment

Beta0.27
Volatility74.09%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.